Physician profile
Jared Hassell
NPI 1811491400
$1,052.99
in general payments reported to CMS, 2019-2025
9 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $238 · 2023: $14.43 · 2024: $127 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $360.28 | 2021-2025 | Dovato, Apretude, Rukobia |
| Gilead Sciences, INC. | $270.47 | 2021-2025 | Biktarvy |
| Abbvie INC. | $186.43 | 2021-2025 | |
| Janssen Products, LP | $99.00 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $53.52 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Biotech, INC. | $30.71 | 2022 | |
| Antares Pharma, INC. | $22.36 | 2025 | Xyosted |
| Hologic Sales and Service, LLC | $15.75 | 2025 | Aptima |
| Theratechnologies INC. | $14.47 | 2024 | Trogarzo, Egrifta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Hassell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.